Desk›Healthcare› FDC Ltd
FDC Ltd
BSE 531599 · NSE FDC · ISIN INE258B01022 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹343.70
-1.38%
BSE close, 28 August 2026
₹5,595.78 cr
16.3 cr shares · Small cap
₹1,682.04 cr
as published
18.9× · 2.45×
EPS ₹18.17 · BV ₹140.29
2,126.33 / 285.92
₹ cr, as filed
20
3 selected · 15%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -34.9% |
|---|---|
| Against 52-week low | +9.2% |
| Day change | -1.38% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹18.17 |
|---|---|
| Price / earnings | 18.92× |
| Price / book | 2.45× |
| Book value — derived, price ÷ P/B | ₹140.29 |
| Return on equity | 12.93% |
| Operating margin | 29.03% |
| Net margin | 20.15% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 12.95%
- ROE as published
- 12.93%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 655.10 | 132.02 | 8.11 | 29.03% | 20.15% |
| Mar-26 · Q | 564.36 | 107.07 | 6.58 | 28.13% | 18.97% |
| FY25-26 | 2,126.33 | 285.92 | 17.56 | 20.81% | 13.45% |
Quarter on quarter
- Revenue, quarter on quarter
- +16.1%
- Net profit, quarter on quarter
- +23.3%
- Operating margin, quarter on quarter
- +90 bps
Disclosure profile 20 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 4 |
| Newspaper Publication | 3 |
| Compliance Certificate | 2 |
| General | 2 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Book Closure | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 17 |
| Total | 20 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
20 filings · 3 selected · busiest 2026-09-01
Filing rhythm · the twelve most recent
2026-09-012026-10-07
SelectedProcedural
Filings
20 in the window · 5 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
28 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Disclosure of Voting results of the 86th Annual general Meeting held on 24th September, 2026 along with the Scrutinizer's Report.
AGM/EGM / AGM View filing →
-
25 September 2026 ·
Closure of Trading Window
Trading window of the Company shall remain closed for all the Designated Persons and their relatives with effect from 1st October , 2026, till 48 hours after the declaration of Unaudited ....
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 86th Annual General Meeting held on Thursday, 24th September 2026.
AGM/EGM / AGM View filing →
-
18 September 2026 ·
Newspaper Publication
Newspaper Publication - Corrigendum to 86th AGM Notice- Cut-off date & Book Closure period FY 2025-26.
Company Update / Newspaper Publication View filing →
-
17 September 2026 ·
Typographical Error In The Notice Of 86Th Annual General Meeting.
This is to inform you that a typographical error has occurred in the notice of the 86th AGM for FY 2025-26. The cutoff date for e-voting shall be read as September 17, 2026, instead of ....
AGM/EGM / AGM View filing →
-
4 September 2026 ·
Newspaper Publication
Newspaper Publication of the convening of the 86th Annual General Meeting of the Company.
Company Update / Newspaper Publication View filing →
-
3 September 2026 ·
Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nandan Mohan Chandavarkar, Mohan Anand ....
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
1 September 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
BRSR for FY 2025-26
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
1 September 2026 ·
Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) 2015
This is to inform you that the register of members and share transfer books of the Company will remain closed from Thursday, September 17, 2026, to Wednesday, September 23, 2026 (both days ....
Corp. Action / Book Closure View filing →
-
1 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for FY 2025-26
Others / Reg. 34 (1) Annual Report View filing →
-
1 September 2026 ·
Notice Of 86Th Annual General Meeting For The FY 2025-26
Please find enclosed Notice of 86th Annual General meeting for the FY 2025-26
AGM/EGM / AGM View filing →
-
1 September 2026 ·
Newspaper Publication
Please find attached copies of the newspaper advertisement in respect of the 86th AGM of the Company
Company Update / Newspaper Publication View filing →
-
27 August 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Announcement under Regulation 30
Company Update / General View filing →
-
13 August 2026 ·
Grant Of Marketing Authorisation From MHRA, UK For Atropine 1.0% W/V Eye Drops, Solution.
This is to inform you that the company's Subsidiary, FDC International Ltd., has received Marketing Authorisation from the MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.
Company Update / General View filing →
-
5 August 2026 ·
Press Release / Media Release
Press Release Q1 FY 2026-27 Results.
Company Update / Press Release / Media Release View filing →
-
5 August 2026 ·
Financial Results For The Quarter Ended June 30, 2026
Financial Results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
5 August 2026 ·
Board Meeting Outcome for Board Meeting Outcome For Outcome For The Board Meeting Held On August 05, 2026.
Outcome for the Board Meeting Held on 5th August, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
27 July 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
23 July 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, August 05, 2026.
FDC Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held ....
Board Meeting / Board Meeting View filing →
RSS feed for FDC Ltd · the 50 most recent filings